National Institute of Allergy and Infectious Diseases; Notice of Closed Meetings, 51545 [2024-13311]
Download as PDF
<![CDATA[
Federal Register / Vol. 89, No. 118 / Tuesday, June 18, 2024 / Notices
Microbiology and Infectious Diseases
Research, National Institutes of Health, HHS)
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
National Institute of Allergy and
Infectious Diseases; Notice of Closed
Meetings
Dated: June 12, 2024.
Lauren A. Fleck,
Program Analyst, Office of Federal Advisory
Committee Policy.
[FR Doc. 2024–13311 Filed 6–17–24; 8:45 am]
BILLING CODE 4140–01–P
lotter on DSK11XQN23PROD with NOTICES1
Pursuant to section 1009 of the
Federal Advisory Committee Act, as
amended, notice is hereby given of the
following meetings.
The meetings will be closed to the
public in accordance with the
provisions set forth in sections
552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,
as amended. The grant applications and
the discussions could disclose
confidential trade secrets or commercial
property such as patentable material,
and personal information concerning
individuals associated with the grant
applications, the disclosure of which
would constitute a clearly unwarranted
invasion of personal privacy.
Name of Committee: National Institute of
Allergy and Infectious Diseases Special
Emphasis Panel; NIAID Investigator Initiated
Program Project Applications (P01 Clinical
Trial Not Allowed).
Date: July 12, 2024.
Time: 10:00 a.m. to 1:30 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institute of Allergy and
Infectious Diseases, National Institutes of
Health, 5601 Fishers Lane, Room 3G31B,
Rockville, MD 20852 (Video Assisted
Meeting).
Contact Person: James T. Snyder, Ph.D.,
Scientific Review Officer, Scientific Review
Program, Division of Extramural Activities,
National Institute of Allergy and Infectious
Diseases, National Institutes of Health, 5601
Fishers Lane, Room 3G31B, Rockville, MD
20852, (240) 669–5060, james.snyder@
nih.gov.
Name of Committee: National Institute of
Allergy and Infectious Diseases Special
Emphasis Panel; NIAID Investigator Initiated
Program Project Applications (P01 Clinical
Trial Not Allowed).
Date: July 12, 2024.
Time: 2:00 p.m. to 5:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institute of Allergy and
Infectious Diseases, National Institutes of
Health, 5601 Fishers Lane, Room 3G31B,
Rockville, MD 20852 (Video Assisted
Meeting).
Contact Person: James T. Snyder, Ph.D.,
Scientific Review Officer, Scientific Review
Program, Division of Extramural Activities,
National Institute of Allergy and Infectious
Diseases, National Institutes of Health, 5601
Fishers Lane, Room 3G31B, Rockville, MD
20852, (240) 669–5060, james.snyder@
nih.gov.
(Catalogue of Federal Domestic Assistance
Program Nos. 93.855, Allergy, Immunology,
and Transplantation Research; 93.856,
VerDate Sep<11>2014
17:57 Jun 17, 2024
Jkt 262001
DEPARTMENT OF HOMELAND
SECURITY
Federal Emergency Management
Agency
[Docket ID: FEMA–2024–0010]
Public Assistance Program and Policy
Guide, FP 104–009–2
Federal Emergency
Management Agency, Department of
Homeland Security.
ACTION: Notice of availability; request
for comment.
AGENCY:
The Federal Emergency
Management Agency (FEMA) is
accepting comments on proposed
revisions to the Public Assistance
Program and Policy Guide (PAPPG)
Version 5.
DATES: Comments must be received no
later than August 19, 2024.
ADDRESSES: You may submit comments,
identified by Docket ID: FEMA–2024–
0010, via the Federal eRulemaking
Portal: https://www.regulations.gov.
Follow the instructions for submitting
comments.
FOR FURTHER INFORMATION CONTACT:
Robert Pesapane, Director, Public
Assistance Division, Federal Emergency
Management Agency, fema-recovery-papolicy@fema.dhs.gov, (202) 646–3834.
SUPPLEMENTARY INFORMATION:
SUMMARY:
I. Public Participation
Interested persons are invited to
submit comments and related materials.
We will consider all comments and
materials received during the comment
period.
If you submit a comment, include the
docket ID, indicate the specific section
of this document to which each
comment applies, and give the reason
for each comment. All submissions may
be posted, without change, to the public
docket at https://www.regulations.gov,
and will include any personal
information you provide. Therefore,
submitting this information makes it
public. For more about privacy and the
docket, visit https://
www.regulations.gov/privacy-notice.
The proposed policy is available in
docket ID FEMA–2024–0010. For access
PO 00000
Frm 00054
Fmt 4703
Sfmt 4703
51545
to the docket to read background
documents or comments received, go to
https://www.regulations.gov and search
for the docket ID.
II. Background
The PAPPG contains consolidated
Public Assistance (PA) Program policies
for the entire disaster recovery life
cycle. The PAPPG provides
comprehensive PA policy to use when
evaluating eligibility. The PAPPG
references and provides weblinks to
other FEMA policies and documents
such as standard operating procedures
and job aids that provide detailed
instructions for individuals involved
with implementing each of the various
steps. This proposed version 5 of the
PAPPG would streamline ways for our
customers to meet requirements through
reducing documentation needs to meet
eligibility, increase accessibility to the
PA program and funding, promote the
equitable treatment and timely recovery
of communities, and effectuate resilient
rebuilding through additional costeffective hazard mitigation measures.
The proposed policy does not have the
force and effect of law.
FEMA seeks comment on the
proposed policy, which is available
online at https://www.regulations.gov
under docket ID FEMA–2024–0010.
Based on the comments received, FEMA
may make appropriate revisions to the
proposed policy. When or if FEMA
issues a final policy, FEMA will publish
a notice of availability in the Federal
Register and make the final policy
available at https://
www.regulations.gov. The final policy
will not have the force and effect of law.
Authority: The Robert T. Stafford
Disaster Relief and Emergency
Assistance Act, as amended (Stafford
Act), 42 U.S.C. 5121 et seq.; 44 CFR part
206.
Deanne Criswell,
Administrator, Federal Emergency
Management Agency.
[FR Doc. 2024–13306 Filed 6–17–24; 8:45 am]
BILLING CODE 9111–23–P
DEPARTMENT OF HOMELAND
SECURITY
Agency Information Collection
Activities: DHS Civil Rights Evaluation
Tool, Collection Instrument DHS Form
3095, OMB Control Number 1601–0024
Department of Homeland
Security (DHS).
ACTION: 30-Day notice and request for
comments; revision request.
AGENCY:
E:\FR\FM\18JNN1.SGM
18JNN1
]]>Agencies
[Federal Register Volume 89, Number 118 (Tuesday, June 18, 2024)]
[Notices]
[Page 51545]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2024-13311]
[[Page 51545]]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
National Institutes of Health
National Institute of Allergy and Infectious Diseases; Notice of
Closed Meetings
Pursuant to section 1009 of the Federal Advisory Committee Act, as
amended, notice is hereby given of the following meetings.
The meetings will be closed to the public in accordance with the
provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5
U.S.C., as amended. The grant applications and the discussions could
disclose confidential trade secrets or commercial property such as
patentable material, and personal information concerning individuals
associated with the grant applications, the disclosure of which would
constitute a clearly unwarranted invasion of personal privacy.
Name of Committee: National Institute of Allergy and Infectious
Diseases Special Emphasis Panel; NIAID Investigator Initiated
Program Project Applications (P01 Clinical Trial Not Allowed).
Date: July 12, 2024.
Time: 10:00 a.m. to 1:30 p.m.
Agenda: To review and evaluate grant applications.
Place: National Institute of Allergy and Infectious Diseases,
National Institutes of Health, 5601 Fishers Lane, Room 3G31B,
Rockville, MD 20852 (Video Assisted Meeting).
Contact Person: James T. Snyder, Ph.D., Scientific Review
Officer, Scientific Review Program, Division of Extramural
Activities, National Institute of Allergy and Infectious Diseases,
National Institutes of Health, 5601 Fishers Lane, Room 3G31B,
Rockville, MD 20852, (240) 669-5060, [email protected].
Name of Committee: National Institute of Allergy and Infectious
Diseases Special Emphasis Panel; NIAID Investigator Initiated
Program Project Applications (P01 Clinical Trial Not Allowed).
Date: July 12, 2024.
Time: 2:00 p.m. to 5:00 p.m.
Agenda: To review and evaluate grant applications.
Place: National Institute of Allergy and Infectious Diseases,
National Institutes of Health, 5601 Fishers Lane, Room 3G31B,
Rockville, MD 20852 (Video Assisted Meeting).
Contact Person: James T. Snyder, Ph.D., Scientific Review
Officer, Scientific Review Program, Division of Extramural
Activities, National Institute of Allergy and Infectious Diseases,
National Institutes of Health, 5601 Fishers Lane, Room 3G31B,
Rockville, MD 20852, (240) 669-5060, [email protected].
(Catalogue of Federal Domestic Assistance Program Nos. 93.855,
Allergy, Immunology, and Transplantation Research; 93.856,
Microbiology and Infectious Diseases Research, National Institutes
of Health, HHS)
Dated: June 12, 2024.
Lauren A. Fleck,
Program Analyst, Office of Federal Advisory Committee Policy.
[FR Doc. 2024-13311 Filed 6-17-24; 8:45 am]
BILLING CODE 4140-01-P
